Biohaven Price to Sales Ratio 2016-2022 | BHVN
Historical PS ratio values for Biohaven (BHVN) over the last 10 years. The current P/S ratio for Biohaven as of March 24, 2023 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Biohaven P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2023-03-24 |
14.29 |
|
1.13 |
| 2022-09-30 |
151.17 |
$12.60 |
12.00 |
| 2022-06-30 |
145.71 |
$12.60 |
11.57 |
| 2022-03-31 |
118.57 |
$11.00 |
10.78 |
| 2021-12-31 |
137.81 |
$7.17 |
19.22 |
| 2021-09-30 |
138.91 |
$2.73 |
50.85 |
| 2021-06-30 |
97.08 |
$3.03 |
32.07 |
| 2021-03-31 |
68.35 |
$1.77 |
38.72 |
| 2020-12-31 |
85.71 |
$1.08 |
79.41 |
| 2020-09-30 |
65.01 |
$0.48 |
135.02 |
| 2020-06-30 |
73.11 |
$0.19 |
394.13 |
| 2020-03-31 |
34.03 |
$0.02 |
1667.85 |
| 2019-12-31 |
54.44 |
0 |
0.00 |
| 2019-09-30 |
41.72 |
0 |
0.00 |
| 2019-06-30 |
43.79 |
0 |
0.00 |
| 2019-03-31 |
51.47 |
0 |
0.00 |
| 2018-12-31 |
36.98 |
0 |
0.00 |
| 2018-09-30 |
37.55 |
0 |
0.00 |
| 2018-06-30 |
39.52 |
0 |
0.00 |
| 2018-03-31 |
25.76 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.913B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
